Thanks billdah, What stands out for me from this broadcast is...

Thanks billdah,
What stands out for me from this broadcast is when Witty says this :

The most expensive part of drug development is the continued prosecution of failing projects. The best way to improve the return of investment is to kill projects early which are going to fail

GSK under its new management stating the above as one of their greatest guidelines to excellency and making money will most definately not continue to " doodle " along with OBJ's technology if they don't see a great outcome of this partnership.

There is much frustration from posters, mostly due to shareprice stagnation, which does not account for the
philosophy of partnership and continued motivated testing from our global partners.